Lisa Wilson | Investor Relations |
Nikhil Lalwani | President and Chief Executive Officer |
Stephen Carey | Chief Financial Officer |
Dana Flanders | Guggenheim |
Elliot Wilbur | Raymond James & Associates |
Brandon Folkes | Cantor Fitzgerald & Co. |
[00:00:04] Good morning and welcome to today's program. My name is Nicole and I will be your conference operator. At the time. I would like to welcome everyone to the Alien Pharmaceuticals third quarter TWENTY TWENTY Earnings Results Conference call. All eyes have been placed on me to prevent any background noise after the Speaker's remarks.